HAEMATO AG (HAM:HAEK)

Germany flag Germany · Delayed Price · Currency is EUR
11.80
+0.10 (0.85%)
At close: Apr 27, 2026
-13.24%
Market Cap 61.69M
Revenue (ttm) 260.81M
Net Income (ttm) 9.61M
Shares Out 5.23M
EPS (ttm) 1.88
PE Ratio 6.29
Forward PE n/a
Dividend 0.04 (0.33%)
Ex-Dividend Date Jul 16, 2025
Volume 1,010
Average Volume 583
Open 11.40
Previous Close 11.70
Day's Range 11.40 - 13.00
52-Week Range 8.20 - 14.10
Beta 0.00
RSI 51.27
Earnings Date n/a

About HAEMATO AG

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1993
Employees 76
Stock Exchange Hamburg Stock Exchange
Ticker Symbol HAEK
Full Company Profile

Financial Performance

In 2022, HAEMATO AG's revenue was 248.14 million, a decrease of -12.95% compared to the previous year's 285.04 million. Earnings were 8.19 million, an increase of 25.39%.

News

There is no news available yet.